Highlights
NASDAQ: SAGE       Sage Therapeutic Com
Last Price Today's Change   Day's Range   Trading Volume
60.10   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):718,352
4 Weeks Range:46.24 - 61.22
4 Weeks Price Volatility (%):
98.17%
52 Weeks Range:25.01 - 166.01
52 Weeks Price Volatility (%):
36.20%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. Sage's lead development program is SAGE-547, it is in Phase 3 clinical trials for super-refractory status epilepticus; and the SAGE-217 program which is in Phase 2 clinical trials for post-partum depression, essential tremor, Parkinson's disease and major depressive disorder. The company is also developing several other compounds for treatment that is in the early stage of development.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2010  3947  233  3092 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AAPL 106.84-3.50 
 LK 1.38+1.38 
 KODK 12.11+1.41 
 ONTX 0.322+0.072 
 GE 6.88-0.17 
 SAVA 10.07+2.98 
 SQQQ 27.48+1.06 
 WFC 25.13+0.02 
 TSLA 442.15+18.72 
 RIG 1.06-0.05 
PARTNERS & BROKERS